Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
33 hedge funds and large institutions have $69.2M invested in Axcella Health Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 8 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
13% less funds holding
Funds holding: 38 → 33 (-5)
21% less capital invested
Capital invested by funds: $87M → $69.2M (-$17.9M)
63% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$168K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$127K |
| 3 |
PPW
Pinnacle Private Wealth
Andover,
Massachusetts
|
+$63K |
| 4 |
Charles Schwab
San Francisco,
California
|
+$35.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$29.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$102K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$23K |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
-$13K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$6.74K |
| 5 |
Morgan Stanley
New York
|
-$1.87K |
AXLA Hedge Fund Activity: Q2 2022 in Review
33 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2022, worth a combined $69.2M — down 21% from $87M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of AXLA and 3 opened new positions — a net loss of 5 holders — while 2 trimmed existing stakes and 10 added.
The largest buyer was Fidelity Investments, adding an estimated $168K. The largest seller was Millennium Management, exiting entirely with an estimated $102K sold.
- 33 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2022, down from 38 in Q1 2022.
- Funds reported $69.2M of Axcella Health Inc. Common Stock stock for Q2 2022, down 21% quarter-over-quarter.
- 3 funds opened new Axcella Health Inc. Common Stock positions in Q2 2022 and 8 closed out, a net change of -5 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q2 2022 was Fidelity Investments, an estimated $168K added.
- The largest Axcella Health Inc. Common Stock seller in Q2 2022 was Millennium Management, an estimated $102K sold.
Based on aggregated 13F filings for Q2 2022.